Regulation of ovarian function in obese women: pathogenetic mechanisms

Abstract

Considering the universally high rates of obesity among the population, including women of reproductive age, and the negative impact of obesity on female fertility, the interest in this problem in the modern world becomes understandable. Many researchers have confirmed the pattern of ovulatory dysfunction development because of metabolic disorders in obese women. The exact mechanism for the development of anovulation and infertility in women with obesity has not been established, however, many pathogenetic factors that affect reproductive function are already known. Obese women have a high risk of developing ovulatory dysfunction due to insulin resistance, hyperandrogenism, as well as subclinical inflammation, lipotoxicity, and disruption of adipokines due to excess adipose tissue, which generally leads to impaired steroidogenesis and regulation in the hypothalamic – pituitary – gonadal axis. Due to the high prevalence of obesity in women of reproductive age, the objective of this review was to examine the pathogenetic mechanisms of the impact of obesity on female fertility, as well as the impact of high body mass index on the results of assisted reproductive technology (ART) cycles. We carried out a literature search in the PubMed database for the entire period of publications using phrases such as “ovarian function + obesity,” “pathogenesis of ovarian dysfunction in obesity,” “ART + obesity,” and “perinatal outcomes + bariatric surgery”. The most relevant studies being selected, with domestic and foreign clinical recommendations used in preparing the manuscript.

Keywords

obesity / anovulation / infertility / assisted reproductive technology

References

[1] Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines “Management of obesity and its comorbidities”. Obesity and metabolism. 2021;18(1):5–99. EDN: AHSBSE doi: 10.14341/omet12714

[2] Дедов И.И., Шестакова М.В., Мельниченко Г.А., и др. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний» // Ожирение и метаболизм. 2021. Т. 18, № 1. C. 5–99. EDN: AHSBSE doi: 10.14341/omet12714

[3] Ministry of Health of the Russian Federation, Russian Association of Endocrinologists, Society of Bariatric Surgeons. Obesity. Clinical guidelines. 2020 [cited 2023 Sept 13]. Available from: https://edu.endocrincentr.ru/sites/default/files/recommendation_pdf/kr28.pdf

[4] Министерство Здравоохранения РФ, Российская ассоциация эндокринологов, Общество бариатрических хирургов. Ожирение. Клинические рекомендации. 2020. Режим доступа: https://edu.endocrincentr.ru/sites/default/files/recommendation_pdf/kr28.pdf. Дата обращения: 13.09.2023

[5] Rosstat. Selective monitoring of the population’s diet in 2018 [cited 2023 Sept 13]. Available from: https://rosstat.gov.ru/storage/mediabank/Racion.pdf

[6] Росстат. Выборочное наблюдение рациона питания населения 2018 год. Режим доступа: https://rosstat.gov.ru/storage/mediabank/Racion.pdf. Дата обращения: 13.09.2023

[7] Heslehurst N, Vieira R, Hayes L, et al. Maternal body mass index and post-term birth: a systematic review and meta-analysis. Obes Rev. 2017;18(3):293–308. doi: 10.1111/obr.12489

[8] Heslehurst N., Vieira R., Hayes L., et al. Maternal body mass index and post-term birth: a systematic review and meta-analysis // Obes Rev. 2017. Vol. 18, N 3. P. 293–308. doi: 10.1111/obr.12489

[9] Wei S, Schmidt MD, Dwyer T, et al. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring). 2009;17(5):1070–1076. doi: 10.1038/oby.2008.641

[10] Wei S., Schmidt M.D., Dwyer T., et al. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin // Obesity (Silver Spring). 2009. Vol. 17, N 5. Р. 1070–1076. doi: 10.1038/oby.2008.641

[11] Wise MR, Gill P, Lensen S, et al. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215(5):598.e1–598.e8. doi: 10.1016/j.ajog.2016.06.006

[12] Wise M.R., Gill P., Lensen S., et al. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women // Am J Obstet Gynecol. 2016. Vol. 215, N 5. P. 598.e1–8. doi: 10.1016/j.ajog.2016.06.006

[13] Podzolkova NM, Koloda YuA, Podzolkov AV. Infertility therapy in obese patients: modern trends. Russian Journal of Human Reproduction. 2012;18(3):37–41. EDN: PEKCFN

[14] Подзолкова Н.М., Колода Ю.А., Подзолков А.В. Терапия бесплодия у пациенток с ожирением: современный взгляд на проблему // Проблемы репродукции. 2012. Т. 18, № 3. С. 37–41. EDN: PEKCFN

[15] Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1):171–177. doi: 10.1016/0002-9378(94)90465-0

[16] Rich-Edwards J.W., Goldman M.B., Willett W.C., et al. Adolescent body mass index and infertility caused by ovulatory disorder // Am J Obstet Gynecol. 1994. Vol. 171, N 1. Р. 171–177. doi: 10.1016/0002-9378(94)90465-0

[17] Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–1159. doi: 10.1111/j.1471-0528.2006.00990.x

[18] Pasquali R., Gambineri A., Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome // BJOG. 2006. Vol. 113, N 10. Р. 1148–1159. doi: 10.1111/j.1471-0528.2006.00990.x

[19] Siddiqui A, Azria E, Howell EA, Deneux-Tharaux C; EPIMOMS Study Group. Associations between maternal obesity and severe maternal morbidity: findings from the French EPIMOMS population-based study. Paediatr Perinat Epidemiol. 2019;33(1):7–16. doi: 10.1111/ppe.12522

[20] Siddiqui A., Azria E., Howell E.A., et al. Associations between maternal obesity and severe maternal morbidity: Findings from the French EPIMOMS population-based study // Paediatr Perinat Epidemiol. 2019. Vol. 33, N 1. Р. 7–16. doi: 10.1111/ppe.12522

[21] García-Ferreyra J, Carpio J, Zambrano M, et al. Overweight and obesity significantly reduce pregnancy, implantation, and live birth rates in women undergoing in vitro fertilization procedures. JBRA Assist Reprod. 2021;25(3):394–402. doi: 10.5935/1518-0557.20200105

[22] García-Ferreyra J., Carpio J., Zambrano M., et al. Overweight and obesity significantly reduce pregnancy, implantation, and live birth rates in women undergoing in vitro fertilization procedures // JBRA Assist Reprod. 2021. Vol. 25, N 3. P. 394–402. doi: 10.5935/1518-0557.20200105

[23] Eapen A, Hayes ET, McQueen DB, et al. Mean differences in maternal body mass index and recurrent pregnancy loss: a systematic review and meta-analysis of observational studies. Fertil Steril. 2021;116(5):1341–1348. doi: 10.1016/j.fertnstert.2021.06.019

[24] Eapen A., Hayes E.T., McQueen D.B. et al. Mean differences in maternal body mass index and recurrent pregnancy loss: a systematic review and meta-analysis of observational studies // Fertil Steril. 2021. Vol. 116, N 5. Р. 1341–1348. doi: 10.1016/j.fertnstert.2021.06.019

[25] Mahutte N, Kamga-Ngande C, Sharma A, et al. Obesity and reproduction. J Obstet Gynaecol Can. 2018;40(7):950–966. doi: 10.1016/j.jogc.2018.04.030

[26] Mahutte N., Kamba-Neanderthal C., Sharma A., et al. Obesity and reproduction // J Obstet Gynaecol Can. 2018. Vol. 40, N 7. P. 950–966. doi: 10.1016/j.jogc.2018.04.030

[27] Andreeva EN, Sheremetyeva EV, Fursenko VA. Obesity — threat to the reproductive potential of Russia. Obesity and metabolism. 2019;16(3):20–28. EDN: SNJRHQ doi: 10.14341/omet10340

[28] Андреева Е.Н., Шереметьева У.В., Фурсенко В.А. Ожирение — угроза репродуктивного потенциала России // Ожирение и метаболизм. 2019. Т. 16, № 3. С. 20–28. EDN: SNJRHQ doi: 10.14341/omet10340

[29] Kabiru W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol. 2004;191(3):928–932. doi: 10.1016/j.ajog.2004.06.051

[30] Karibu W., Raynor B.D. Obstetric outcomes associated with increase in BMI category during pregnancy // Am J Obstet Gynecol. 2004. Vol. 191, N 3. P. 928–932. doi: 10.1016/j.ajog.2004.06.051

[31] Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can. 2013;35(7):606–611. doi: 10.1016/S1701-2163(15)30879-3

[32] Crane J.M., Murphy P., Burrage L., et al. Maternal and perinatal outcomes of extreme obesity in pregnance // J Obstet Gynaecol Can. 2013. Vol. 35, N 7. Р. 606–611. doi: 10.1016/S1701-2163(15)30879-3

[33] Marshalov DV, Shifman EM, Salov IA, et al. Obesity as a risk factor for massive postpartum hemorrhage. Russian Journal of Anesthesiology and Reanimatology. 2016;61(4):283–289. EDN: WKNOZZ doi: 10.18821/0201-7563-2016-61-4-283-289

[34] Маршалов Д.В., Шифман Е.М., Салов И.А., и др. Ожирение как фактор риска массивного послеродового кровотечения // Анестезиология и реаниматология. 2016. Т. 61, № 4. С. 283–289. EDN: WKNOZZ doi: 10.18821/0201-7563-2016-61-4-283-289

[35] Kan NI, Fedorina TA, Nikolaeva-Ball DR, et al. Functional state of fetoplacental complex in pregnant women with obesity and metabolic syndrome. Ulyanovsk Medico-biological Journal. 2017;(3):71–81. EDN: ZGZREH doi: 10.23648/UMBJ.2017.27.7078

[36] Кан Н.И., Федорина Т.А, Николаева-Балл Д.Р., Ванина Л.Н. Функциональное состояние фетоплацентарного комплекса у беременных с ожирением и метаболическим синдромом // Ульяновский медико-биологический журнал. 2017. № 3. С. 71–81. EDN: ZGZREH doi: 10.23648/UMBJ.2017.27.7078

[37] van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324–328. doi: 10.1093/humrep/dem371

[38] van der Steeg J.W., Steures P., Eijkemans M.J., et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women // Hum Reprod. 2008. Vol. 23, N 2. P. 324–328. doi: 10.1093/humrep/dem371

[39] Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107(4):840–847. doi: 10.1016/j.fertnstert.2017.01.017

[40] Broughton D.E., Moley K.H. Obesity and female infertility: potential mediators of obesity’s impact // Fertil Steril. 2017. Vol. 107, N 4. P. 840–847. doi: 10.1016/j.fertnstert.2017.01.017

[41] Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–825. doi: 10.1016/S0140-6736(11)60814-3

[42] Wang Y.C., McPherson K., Marsh T., et al. Health and economic burden of the projected obesity trends in the USA and the UK // Lancet. 2011. Vol. 378, N 9793. P. 815–825. doi: 10.1016/S0140-6736(11)60814-3

[43] Fedorcsák P, Dale PO, Storeng R, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004;19(11):2523–2528. doi: 10.1093/humrep/deh485

[44] Fedorcsák P., Dale P.O., Storeng R., et al. Impact of overweight and underweight on assisted reproduction treatment // Hum Reprod. 2004. Vol. 19, N 11. P. 2523–2528. doi: 10.1093/humrep/deh485

[45] Provost MP, Acharya KS, Acharya CR, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2016;105(3):663–669. doi: 10.1016/j.fertnstert.2015.11.008

[46] Provost M.P., Acharya K.S., Acharya C.R., et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry // Fertil Steril. 2016. Vol. 105, N 3. P. 663–669. doi: 10.1016/j.fertnstert.2015.11.008

[47] Maged AM, Fahmy RM, Rashwan H, et al. Effect of body mass index on the outcome of IVF cycles among patients with poor ovarian response. Int J Gynaecol Obstet. 2019;144(2):161–166. doi: 10.1002/ijgo.12706

[48] Maged A.M., Fahmy R.M., Rashwan H., et al. Effect of body mass index on the outcome of IVF cycles among patients with poor ovarian response // Int J Gynaecol Obstet. 2019. Vol. 144, N 2. P. 161–166. doi: 10.1002/ijgo.12706

[49] Banker M, Sorathiya D, Shah S. Effect of body mass index on the outcome of in-vitro fertilization/intracytoplasmic sperm injection in women. J Hum Reprod Sci. 2017;10(1):37–43. doi: 10.4103/jhrs.JHRS_75_16

[50] Banker M., Sorathiya D., Shah S. Effect of body mass index on the outcome of in-vitro fertilization/intracytoplasmic sperm injection in women // J Hum Reprod Sci. 2017. Vol. 10, N 1. P. 37–43. doi: 10.4103/jhrs.JHRS_75_16

[51] Druzhinina AS, Vitiazeva II, Dimitrova DA. Correlation of in vitro fertilization (IVF) infertility treatment outcomes and body weight index in women of reproductive age. Problems of Endocrinology. 2021;67(1):76–82. EDN: BKYROD doi: 10.14341/probl12727

[52] Дружинина А.С., Витязева И.И., Димитрова Д.А. Корреляция исходов лечения бесплодия методом экстракорпорального оплодотворения (ЭКО) и массы тела женщин репродуктивного возраста // Проблемы эндокринологии. 2021. Т. 67, № 1. С. 76–82. EDN: BKYROD doi: 10.14341/probl12727

[53] Insogna IG, Lee MS, Reimers RM, et al. Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer. Fertil Steril. 2017;108(5):770–776.e1. doi: 10.1016/j.fertnstert.2017.08.024

[54] Insogna I.G., Lee M.S., Reimers R.M., et al. Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer // Fertil Steril. 2017. Vol. 108, N 5. P. 770–776. doi: 10.1016/j.fertnstert.2017.08.024

[55] Mathew H, Castracane VD, Mantzoros C. Adipose tissue and reproductive health. Metabolism. 2018;86:18–32. doi: 10.1016/j.metabol.2017.11.006

[56] Mathew H., Castracane V.D., Mantzoros C. Adipose tissue and reproductive health // Metabolism. 2018. Vol. 86. P. 18–32. doi: 10.1016/j.metabol.2017.11.006

[57] Dubinskaya ED, Aleshkina EV, Gasparov AS, et al. Obesity and fertility. Problems of Gynecology, Obstetrics and Perinatology. 2018;17(6):76–84. EDN: YUGSLJ doi: 10.20953/1726-1678-2018-6-76-84

[58] Дубинская Е.Д., Алёшкина Е.В., Гаспаров А.С. и др. Ожирение и фертильность // Вопросы гинекологии, акушерства и перинатологии. 2018. Т. 17, № 6. С. 76–84. EDN: YUGSLJ doi: 10.20953/1726-1678-2018-6-76-84

[59] Estienne A, Bongrani A, Reverchon M, et al. Involvement of novel adipokines, chemerin, visfatin, resistin and apelin in reproductive functions in normal and pathological conditions in humans and animal models. Int J Mol Sci. 2019;20(18):4431. doi: 10.3390/ijms20184431

[60] Estienne A., Bongrani A.., Reverchon M., et al. Involvement of novel adipokines, chemerin, visfatin, resistin and apelin in reproductive functions in normal and pathological conditions in humans and animal models // Int J Mol Sci. 2019. Vol. 20, N 18. P. 4431. doi: 10.3390/ijms20184431

[61] Elagin IB, Orazov MR, Kharnas SS, et al. The pathogenesis of reproductive disorders in women suffering from morbid obesity. Moscow Surgical Journal. 2019;(2):43–52. EDN: NLPBWV doi: 10.17238/issn2072-3180.2019.2.43-52

[62] Елагин И.Б., Оразов М.Р., Харнас С.С., и др. Патогенез нарушений репродуктивного здоровья у женщин, страдающих морбидным ожирением // Московский хирургический журнал. 2019. № 2(66). C. 43–52. EDN: NLPBWV doi: 10.17238/issn2072-3180.2019.2.43-52

[63] Petrus P, Rosqvist F, Edholm D, et al. Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression. Lipids Health Dis. 2015;14:42. doi: 10.1186/s12944-015-0042-1

[64] Petrus P., Rosqvist F., Edholm D., et al. Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression // Lipids Health Dis. 2015. Vol. 14. P. 42. doi: 10.1186/s12944-015-0042-1

[65] Giviziez CR, Sanchez EG, Approbato MS, et al. Obesity and anovulatory infertility: a review. JBRA Assist Reprod. 2016;20(4):240–245. doi: 10.5935/1518-0557.20160046

[66] Giviziez C.R., Sanchez E.G., Approbato M.S., et al. Obesity and anovulatory infertility: a review // JBRA Assist Reprod. 2016. Vol. 20, N 4. P. 240–245. doi: 10.5935/1518-0557.20160046

[67] Gambineri A, Laudisio D, Marocco C, et al. Female infertility: which role for obesity? Int J Obes Suppl. 2019;9(1):65–72. doi: 10.1038/s41367-019-0009-1

[68] Gambineri A., Laudisio D., Marocco C., et al. Obesity programs of nutrition, education, research and assessment (OPERA) group. female infertility: which role for obesity? // Int J Obes Suppl. 2019. Vol. 9, N 1. P. 65–72. doi: 10.1038/s41367-019-0009-1

[69] Zhao H, Zhou L, Shangguan AJ, et al. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol. 2016;57(1):R19–R33. doi: 10.1530/JME-15-0310

[70] Zhao H., Zhou L., Shangguan A.J., et al. Aromatase expression and regulation in breast and endometrial cancer // J Mol Endocrinol. 2016. Vol. 57, N 1. P. R19–R33. doi: 10.1530/JME-15-0310

[71] Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Obesity and metabolism. 2017;14(1):3–8. EDN: YRUSJB doi: 10.14341/omet201713-8

[72] Горбатенко Н.В., Беженарь В.Ф., Фишман М.Б. Влияние ожирения на развитие нарушения репродуктивной функции у женщин // Ожирение и метаболизм. 2017. Т. 14, № 1. С. 3–8. EDN: YRUSJB doi: 10.14341/omet201713-8

[73] Isaeva AP, Gapparova KM, Chekhonina YuG., et al. Characteristics of free fatty acid metabolism in pathogenesis of obesity: current view. Problems of Nutrition. 2018;87(1):18–27. EDN: YRZCFQ doi: 10.24411/0042-8833-2018-10002

[74] Исаева А.П., Гаппарова К.М., Чехонина Ю.Г., и др. Свободные жирные кислоты и ожирение: состояние проблемы // Вопросы питания. 2018. Т. 87, № 1. С. 18–27. EDN: YRZCFQ doi: 10.24411/0042-8833-2018-10002

[75] Liu R, Nikolajczyk BS. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587. doi: 10.3389/fimmu.2019.01587

[76] Liu R., Nikolajczyk B.S. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond // Front Immunol. 2019. Vol. 10. P. 1587. doi: 10.3389/fimmu.2019.01587

[77] Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127(1):74–82. doi: 10.1172/JCI88883

[78] Crewe C., An Y.A., Scherer P.E. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis // J Clin Invest. 2017. Vol. 127, N 1. Р. 74–82. doi: 10.1172/JCI88883

[79] Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830. doi: 10.1172/jci200319451

[80] Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance // J Clin Invest. 2003. Vol. 112, N 12. Р. 1821–1830. doi: 10.1172/jci200319451

[81] Kolb H, Stumvoll M, Kramer W, et al. Insulin translates unfavourable lifestyle into obesity. BMC Med. 2018;16(1):232. doi: 10.1186/s12916-018-1225-1

[82] Kolb H., Stumvoll M., Kramer W., et al. Insulin translates unfavourable lifestyle into obesity // BMC Med. 2018. Vol. 16, N 1. P. 232. doi: 10.1186/s12916-018-1225-1

[83] Williams KJ, Wu X. Imbalanced insulin action in chronic over nutrition: clinical harm, molecular mechanisms, and a way forward. Atherosclerosis. 2016;247:225–282. doi: 10.1016/j.atherosclerosis.2016.02.004

[84] Williams K.J., Wu X. Imbalanced insulin action in chronic over nutrition: clinical harm, molecular mechanisms, and a way forward // Atherosclerosis. 2016. Vol. 247. P. 225–282. doi: 10.1016/j.atherosclerosis.2016.02.004

[85] Aganezova NV, Aganezov SS. Obesity and female reproductive health. Obstetrics and Gynecology. 2016;(6):18–25. EDN: WGAYHF doi: 10.18565/aig.2016.6.18-25

[86] Аганезова Н.В., Аганезов С.С. Ожирение и репродуктивное здоровье женщины // Акушерство и гинекология. 2016. № 6. C. 18–25. EDN: WGAYHF doi: 10.18565/aig.2016.6.18-25

[87] Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800. doi: 10.1210/edrv.18.6.0318

[88] Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis // Endocr Rev. 1997. Vol. 18, N 6. Р. 774–800. doi: 10.1210/edrv.18.6.0318

[89] Dedov II, Melnichenko GA, Andreeva EN, et al. Polycystic ovary syndrome. Moscow: Medical Information Agency; 2007. 368 p. EDN: TSFPRP (In Russ.)

[90] Дедов И.И., Мельниченко Г.А, Андреева Е.Н., и др. Синдром поликистозных яичников. Москва: Медицинское информационное агентство, 2007. 368 с. EDN: TSFPRP

[91] Demidova TYu, Gritskevich EYu. Role of obesity in development of reproductive disorders and possibilities of risk management. RMJ. 2018;26(11–2):105–109. EDN: YOCINV

[92] Демидова Т.Ю., Грицкевич Е.Ю. Роль ожирения в развитии репродуктивных нарушений и возможности преодоления рисков // РМЖ. Эндокринология. 2018. Т. 26, № 11-2. С. 105–109. EDN: YOCINV

[93] Liu Z, Wang Z, Hao C, et al. Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis. Reprod Biol Endocrinol. 2018;16(1):120. doi: 10.1186/s12958-018-0439-6

[94] Liu Z., Wang Z., Hao C, et al. Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis // Reprod Biol Endocrinol. 2018. Vol. 16, N 1. P. 120. doi: 10.1186/s12958-018-0439-6

[95] Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27(2):541–549. doi: 10.1093/humrep/der418

[96] Panidis D., Tziomalos K., Misichronis G., et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study // Hum Reprod. 2011. Vol. 27, N 2. P. 541–549. doi: 10.1093/humrep/der418

[97] Ding H, Zhang J, Zhang F, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12. doi: 10.3389/fendo.2021.741764

[98] Ding H., Zhang J., Zhang F., et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome // Front Endocrinol. 2021. Vol. 12. doi: 10.3389/fendo.2021.741764

[99] Sermondade N, Huberlant S, Bourhis-Lefebvre V, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439–451. doi: 10.1093/humupd/dmz011

[100] Sermondade N., Huberlant S., Bourhis-Lefebvre V., et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis // Hum Reprod Update. 2019. Vol. 25, N 4. P. 439–451. doi: 10.1093/humupd/dmz011

[101] Zhao Z, Jiang X, Li J, et al. The combined impact of female and male body mass index on cumulative pregnancy outcomes after the first ovarian stimulation. Front Endocrinol (Lausanne). 2021;12. doi: 10.3389/fendo.2021.735783

[102] Zhao Z., Jiang X., Li J., et al. The combined impact of female and male body mass index on cumulative pregnancy outcomes after the first ovarian stimulation // Front Endocrinol (Lausanne). 2021. Vol. 12. doi: 10.3389/fendo.2021.735783

[103] Xiong Y, Wang J, Huang S, et al. Association between maternal prepregnancy body mass index and pregnancy outcomes following assisted reproductive technology: a systematic review and dose-response meta-analysis. Obes Rev. 2021;22(6). doi: 10.1111/obr.13219

[104] Xiong Y., Wang J., Huang S., et al. Association between maternal prepregnancy body mass index and pregnancy outcomes following assisted reproductive technology: a systematic review and dose-response meta-analysis // Obes Rev. 2021. Vol. 22, N 6. doi: 10.1111/obr.13219

[105] Toftager M, Bogstad J, Løssl K, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod. 2017;32(3):556–567. doi: 10.1093/humrep/dew358

[106] Toftager M., Bogstad J., Løssl K., et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols // Hum Reprod. 2017. Vol. 32, N 3. P. 556–567. doi: 10.1093/humrep/dew358

[107] Mitchell GW, Rogers J. The influence of weight reduction on amenorrhea in obese women. N Engl J Med. 1953;249(21):835–837. doi: 10.1056/NEJM195311192492102

[108] Mitchell G.W., Rogers J. The influence of weight reduction on amenorrhea in obese women // N Engl J Med 1953. Vol. 249, N 21. P. 835–837. doi: 10.1056/NEJM195311192492102

[109] Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Russian Journal of Cardiology. 2020;25(4):101–161. (In Russ.) EDN: CJIJDF doi: 10.15829/1560-4071-2020-3839

[110] Cosentino F., Grant P.J., Aboyans V., et al. 2019 Рекомендации ЕSC/EASD по сахарному диабету, предиабету и сердечно-сосудистым заболеваниям // Российский кардиологический журнал. 2020. Т. 25, № 4. С. 101–161. EDN: CJIJDF doi: 10.15829/1560-4071-2020-3839

[111] Brown RCH. Irresponsibly infertile? Obesity, Efficiency, and exclusion from treatment. Health Care Anal. 2019;27(2):61–76. doi: 10.1007/s10728-019-00366-w

[112] Brown R.C. Irresponsibly infertile? Obesity, efficiency, and exclusion from treatment // Health Care Anal. 2019. Vol. 27, N 2. P. 61–76. doi: 10.1007/s10728-019-00366-w

[113] Dedov II, Melnichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53–70. EDN: OUJNNF doi: 10.14341/omet2018153-70

[114] Дедов И.И., Мельниченко Г.А., Шестакова М.В., и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-ий пересмотр (лечение морбидного ожирения у взрослых) // Ожирение и метаболизм. 2018. Т. 15, № 1. С. 53–70. EDN: OUJNNF doi: 10.14341/omet2018153-70

[115] Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures — 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists — executive summary. Endocr Pract. 2019;25(12):1346–1359. doi: 10.4158/GL-2019-0406

[116] Mechanick J.I., Apovian C., Brethauer S., et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists — executive summary // Endocr Pract. 2019. Vol. 25, N 12. P. 1346–1359. doi: 10.4158/GL-2019-0406

[117] Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573–580. doi: 10.1016/j.ajog.2018.02.003

[118] Kwong W., Tomlinson G., Feig D.S. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? // Am J Obstet Gynecol. 2018. Vol. 218, N 6. Р. 573–580. doi: 10.1016/j.ajog.2018.02.003

[119] Parent B, Martopullo I, Weiss NS, et al. Bariatric surgery in women of childbearing age, timing between an operation and birth, and associated perinatal complications. JAMA Surg. 2017;152(2):128–135. doi: 10.1001/jamasurg.2016.3621

[120] Parent B., Martopullo I., Weiss N.S., et al. Bariatric surgery in women of childbearing age, timing between an operation and birth, and associated perinatal complications // JAMA Surg. 2017. Vol. 152, N 2. Р. 128–135. doi: 10.1001/jamasurg.2016.3621

[121] Akhter Z, Rankin J, Ceulemans D, et al. Pregnancy after bariatric surgery and adverse perinatal outcomes: a systematic review and meta-analysis. PLoS Med. 2019;16(8). doi: 10.1371/journal.pmed.1002866

[122] Akhter Z., Rankin J., Ceulemans D., et al. Pregnancy after bariatric surgery and adverse perinatal outcomes: A systematic review and meta-analysis // PLoS Med. 2019. Vol. 16, N 8. doi: 10.1371/journal.pmed.1002866

[123] Saif T, Strain GW, Dakin G, et al. Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery. Surg Obes Relat Dis. 2012;8(5):542–547. doi: 10.1016/j.soard.2012.01.013

[124] Strain G.W, Dakin G., Gagner M., et al. Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery // Surg Obes Relat Dis. 2012. Vol. 8, N 5. P. 542–547. doi: 10.1016/j.soard.2012.01.013

RIGHTS & PERMISSIONS

Eсо-Vector